pod@musty.io
For verified host and producer emails, sign up to view.
Episodes: 161
Frequency: Irregular
Rating: 5.0/5.0
Estimated listeners: 1k-10k
Gender skew: Male
Location: United Kingdom
YouTube: 2.0k subscribers
pod@musty.io
For verified host and producer emails, sign up to view.
Mustafa (Musty.io) - Host of Big Picture Medicine (health entrepreneurship podcast). Focuses on “big picture” healthcare and health-tech entrepreneurship, with interviews of biotech/healthcare leaders and operators dis...
Joe DeVivo - Building And Scaling A Medtech Turnaround; Runway Strategy And Operating Lessons After A Major Exit; Medtech Board/financing Dynamics
Tom Bartlett - Architecture And Costs Of The NHS Federated Data Platform; Feasibility Of Alternatives; Procurement/relationship Questions Involving Palantir; Implications For NHS Decision-making
Ala Alenazi, PhD - Healthcare AI / Ecosystem Perspectives; Investment Or Scaling Lens On Biotech/health Innovation
Jared Dashevsky, MD - Healthcare AI “broker” Concept And Market Emergence; Broader Implications For Healthcare AI And Ecosystem Dynamics
#141 $1.1B exit... then a MedTech with 12mo of runway called — Joe DeVivo (Butterfly Network)
May 27, 2026
Part 2 with Joe DeVivo, the MedTech CEO who sold InTouch to Teladoc for over $1B and promised himself never to do another turnaround. Two years later, the board of Butterfly Network called w/12mo cash left. Here's how he did it.
#140 Should the NHS Trigger the £330M Palantir Break Clause? An Insider's Take
May 11, 2026
Tom Bartlett spent 22 years inside the NHS. For three and a half years, he led the 150-person engineering team at NHS England that built the £330M Federated Data Platform with Palantir.He left a month ago and he's the only insider speaking publicly about what the platform actually does, what it costs, and whether the NHS has any credible alternative.We cover the architecture, the cost, the CLOUD Act, the BMJ exposé, the conflicts of interest at Chelsea & Westminster, and whether minis...
🔥News: The New Healthcare AI Broker, Palantir Under Fire and Big Tech's Drug Discovery Mirage
May 09, 2026
Jared Dashevsky, MD (Healthcare Huddle) and Ala Alenazi, PhD (Kinnevik) join Mustafa to discuss:The rise of the AI Broker (a middleman that's about to emerge)Palantir's £330M NHS break clauseOpenAI as pharma. We also discuss why drug discovery needs a "Human Genome Project 2.0"
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings